LWAM
RPRX icon

Legacy Wealth Asset Management’s Royalty Pharma RPRX Stock Holding History

Legacy Wealth Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$356K Buy
+6,098
New +$360K 0.08% 303

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Legacy Wealth Asset Management's RPRX Position: Q3 2026 in Review

Legacy Wealth Asset Management opened a new position in Royalty Pharma (RPRX) in Q3 2026: 6,098 shares worth $356K. The stake represents 0.08% of the portfolio and ranks #303 among its holdings.

21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Legacy Wealth Asset Management held 6,098 shares of Royalty Pharma worth $356K as of Q3 2026.
  • Royalty Pharma was a new Legacy Wealth Asset Management position in Q3 2026.
  • Royalty Pharma made up 0.08% of Legacy Wealth Asset Management's portfolio in Q3 2026, its #303 holding.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.